References
- Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis. 1991;11:31–39.
- Loftus EV Jr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91–96.
- Lunder AK, Hov JR, Biryhner A, et al. Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease. Gastroenterology. 2016;151:660–669.
- Weersma RK, Lindor KD. Shifting paradigm: what is the true prevalence and clinical course of primary sclerosing cholangitis? Gastroenterology. 2016;151:590–593.
- Björnsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology. 2008;134:975–980.
- Karlsen TH. Primary sclerosing cholangitis: 50 years of a gut-liver relationship and still no love? Gut. 2016;65:1579–1581.
- Beuers U, Gershwin E, Gish RG, et al. Changing nomenclature for PBC: from ‘Cirrhosis’ to ‘Cholangitis’. Gastroenterology. 2015;149:1627–1629.
- Poupon RE, Lindor KD, Cauch-Dudek K, et al. Combined analysis of randomized trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 1997;113:884–890.
- Wang L, Zhang F-C, Zhang X. Therapeutic advances for primary biliary cholangitis: the old and the new. Eur J Gastroenterol Hepatol. 2016;28:615–621.
- Dumont M, Erlinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology. 1980;79:82–89.